H.R. 5158: To amend the Federal Food, Drug, and Cosmetic Act regarding the approval of combination products consisting of a generic drug and a device, and for other purposes.
Sponsors
1 sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Sep. 04, 2025 | Introduced in House |
| Sep. 04, 2025 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.